Bank of America Corp DE reduced its stake in Eni SpA by 20.4% in the first quarter, selling 179,254 shares and retaining 701,374 shares valued at $39.7 million. Despite beating analyst earnings expectations with $1.76 per share, Eni's revenue of $25.87 billion missed the …
Stifel Financial (SF) stock has delivered significant returns over the past three years but now appears fairly valued, trading at a P/E ratio of 13.9x, which is below the industry average but close to Simply Wall St's fair P/E of 15.3x. The article suggests …
Xenia Hotels & Resorts Inc. (NYSE: XHR) is exhibiting weak near and mid-term sentiment, potentially challenging its long-term positive outlook. The stock is testing resistance, with models suggesting a potential short setup offering a 28.8:1 risk-reward ratio targeting a 9.0% downside. Institutional trading strategies …
MacroGenics Inc (NASDAQ: MGNX) reported second-quarter earnings per share (EPS) of $-1.10, missing analyst estimates by $1.02, and revenue of $32.83M, which fell short of the consensus estimate of $59.14M. The company's stock has seen significant volatility, being down 4.00% in the last three …
MacroGenics (NASDAQ: MGNX) reported a Q2 2026 adjusted EPS of $(0.27), significantly missing the $(0.13) estimate, and revenue of $32.832 million, falling short of the $67.456 million forecast despite a 47.62% YoY increase. The company posted a net income of $19.5 million, a turnaround …
MacroGenics reported its second quarter 2026 financial results, highlighting a significant corporate restructuring including the sale of its manufacturing operations for $122.5 million. This transition to a fully outsourced model has streamlined the company, reducing its workforce to approximately 140 people to focus on …
* MacroGenics press release [https://seekingalpha.com/pr/20619132-macrogenics-reports-second-quarter-2026-financial-results-streamlined-operating-model-and] (MGNX [https://seekingalpha.com/symbol/MGNX]): Q2 GAAP EPS of -$1.10 misses by $1.02. * Revenue of $32.83M (+377.9% Y/Y) misses by $26.31M. MORE ON MACROGENICS * MacroGenics: Whipsaws On Clinical Data, But The Big Picture Is Still Important [https://seekingalpha.com/article/4925873-macrogenics-whipsaws-on-clinical-data-but-the-big-picture-is-still-important] * MacroGenics: 'Hold' …
Wellington Management Group LLP and its related entities have reported a 4.42% beneficial ownership stake in Xenia Hotels & Resorts, Inc. (XHR) as of June 30, 2026. This stake, totaling 4,081,029 shares, is held for their investment advisory clients, with shared voting power over …
Xenia Hotels & Resorts (XHR) recently completed a US$136.91 million equity offering and simultaneously cut its full-year 2026 earnings guidance, leading to an 8.1% stock drop. This move shifts the company's focus from share repurchases to balance sheet reinforcement amidst macroeconomic uncertainty. The new …
B. Riley Financial has reiterated its "Buy" rating for Runway Growth Finance (NASDAQ:RWAY), raising its price target to $11, suggesting a 59% upside. This comes after the company exceeded quarterly earnings expectations, reporting $0.43 EPS against an estimated $0.29, and $37.03 million in revenue …
MacroGenics Inc. (MGNX) reported second-quarter earnings of $19.5 million, or 31 cents per share, significantly exceeding Wall Street's expectation of a 40-cent loss per share. However, the biopharmaceutical company's revenue of $32.8 million fell short of the $44 million forecast by analysts. The earnings …
Fresenius Medical Care stock is trading near $24, with a slight decline of 0.67% on the NYSE and 0.28% in Europe, as investors analyze the company's latest capital market update. This update details recent share repurchases and trading activity, suggesting a strategy to optimize …
B. Riley Financial reduced its price target for Forward Industries (NASDAQ:FWDI) to $7.00 from $8.00 but maintained a "buy" rating, indicating a potential 61.85% upside. The company recently reported a significant quarterly loss of $0.80 per share, missing estimates, and analysts project a full-year …
B. Riley Financial has lowered its price target for Bitdeer Technologies Group (NASDAQ:BTDR) to $21 from $23, though it maintained a "buy" rating, suggesting a significant upside. Despite the lowered target, analyst sentiment remains largely positive, with a "Moderate Buy" consensus and an average …
B. Riley has increased its price target for Runway Growth Finance (RWAY) to $11 from $10, while maintaining a Buy rating on the stock. This adjustment comes amidst recent company news, including Q2 2026 earnings, CEO changes, and a dividend announcement. The article also …
This article reports on Sonida Senior Living Inc.'s Form 8K filing for August 13. Form 8K is a crucial SEC filing that companies must make to announce major events that shareholders should know about. The brief piece indicates that Investing.com published the news.
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 11:00 a.m. ET CALL PARTICIPANTS Vice President, Investor Relations - Randy Bhatia Chairman, President and Chief Executive Officer - Jack Fusco Executive Vice President and Chief Commercial Officer - Anatol Feygin Executive Vice …
Sonida Senior Living (NYSE:SNDA) announced a new $380 million senior secured term loan agreement with Ally Bank, signed on August 7, 2026. This new financing amends an existing agreement and provides an initial advance of $372.5 million, secured by 28 communities. The loan has …
Zacks Research downgraded Cheniere Energy (NYSE:LNG) from a "strong-buy" to a "hold" rating, though the consensus among other analysts remains a "moderate buy." The stock opened at $267.91, near its 52-week high, with institutional investors holding a significant 87.26% of shares. Other recent analyst …
Mizuho increased its price target for Cheniere Energy (NYSE:LNG) to $300 from $273, maintaining an Outperform rating after the company's strong Q2 earnings beat and positive operational update. Cheniere reported adjusted EBITDA of $1.8 billion, driven by higher LNG volumes and marketing margins, and …
Brookdale Senior Living (BKD) reported a swing to net profit in Q2 2026 despite lower revenue, with earnings of US$0.10 per share. The company reaffirmed its 2026 adjusted EBITDA outlook and strengthened its balance sheet through refinancing, aiming for sustained profitability despite ongoing revenue …
Royal Bank of Canada significantly increased its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 479.2% in the first quarter, acquiring 179,418 additional shares. This brings their total holdings to 216,861 shares, valued at approximately $4.9 million. Despite the substantial purchase, …
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.